. "e the FDA to re-evaluate and revoke this decision, pointing out that Lemtrada has been approved in other markets including Canada, Europe, Mexico, and Australia.Coles and Compston were both involved in the clinical trials of Lemtrada and say they have complete confidence in the results of the phase II CAMMS223 study and phase III CARE-MS1 and CARE-MS2 studies\" which supported the marketing appli" . . .